Resources for Food and Drug Administration (FDA)

FDA to aid tropical disease research

www.checkbiotech.org

The Food and Drug Administration, the US regulator, is to unveil a pioneering mechanism this year that rewards pharmaceutical companies for their research into previously neglected diseases with vouchers for accelerated drug reviews.
These vouchers – highly valuable as they might speed up market access for new medicines – can then be sold on to other companies, which can use them for any drug.

The FDA is planning the launch of the “priority review vouchers” (PRVs) in August. The vouchers are designed to stimulate research into tropical ­diseases, for which there is little commercial market.

View the Resource

Share or bookmarklet this web page at: